Common use of Rule 424 Prospectus Clause in Contracts

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor shall use its reasonable best efforts to comment upon such prospectus within one (1) Business Day from the date the Investor receives the final pre-filing version of such prospectus.

Appears in 148 contracts

Samples: Registration Rights Agreement (Frelii, Inc.), Registration Rights Agreement (Premier Biomedical Inc), Registration Rights Agreement (Mphase Technologies Inc)

AutoNDA by SimpleDocs

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities 1933 Act, the prospectus and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor shall use its reasonable best efforts to comment upon such prospectus within one (1) Business Trading Day from the date the Investor receives the final pre-filing version of such prospectus.

Appears in 59 contracts

Samples: Registration Rights Agreement (Insignia Solutions PLC), Registration Rights Agreement (Usurf America Inc), Registration Rights Agreement (Golden Phoenix Minerals Inc /Mn/)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor shall use its reasonable best efforts to comment upon such prospectus within one (1) Business Day from the date the Investor receives the final pre-filing version of such prospectus.

Appears in 40 contracts

Samples: Registration Rights Agreement (Elite Pharmaceuticals Inc /Nv/), Registration Rights Agreement (Westmountain Gold, Inc.), Registration Rights Agreement (Naked Brand Group Inc.)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities 1933 Act, the prospectus and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor shall use its reasonable best efforts to comment upon such prospectus within one (1) Business Day from the date the Investor receives the final pre-filing version of such prospectus.

Appears in 27 contracts

Samples: Registration Rights Agreement (GreenChek Technology Inc.), Registration Rights Agreement (Neoprobe Corp), Registration Rights Agreement (MultiCell Technologies, Inc.)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor shall use its reasonable best efforts to comment upon such prospectus within one (1) Business Day from the date the Investor receives the substantially final pre-filing version of such prospectus.

Appears in 17 contracts

Samples: Registration Rights Agreement (Organicell Regenerative Medicine, Inc.), Registration Rights Agreement (PECK Co HOLDINGS, INC.), Registration Rights Agreement (Growth Capital Acquisition Corp.)

Rule 424 Prospectus. The In addition to the Initial Registration Statement, the Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus such prospectuses and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the each Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prospectuses prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor shall use its reasonable best efforts to comment upon such any prospectus within one two (12) Business Day business days from the date the Investor receives the final pre-filing version of such prospectus.

Appears in 15 contracts

Samples: Registration Rights Agreement (Sphere 3D Corp), Registration Rights Agreement (Globavend Holdings LTD), Registration Rights Agreement (Digital Brands Group, Inc.)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SECCommission, pursuant to Rule 424 promulgated under the Securities Act, the prospectus prospectus, amendments and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such commentsCommission. The Investor shall use its reasonable best efforts to comment upon such prospectus within one (1) Business Day two Trading Days from the date the Investor receives the proposed final pre-filing version of such prospectus.

Appears in 10 contracts

Samples: Registration Rights Agreement (Med-X, Inc.), Share Purchase Agreement (FibroBiologics Inc.), Share Purchase Agreement (Surf Air Mobility Inc.)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SECCommission, pursuant to Rule 424 promulgated under the Securities Act, the prospectus prospectus, amendments and prospectus supplements, if any, to be used in connection with offers and sales of the Registrable Securities under the Registration Statement. The Investor and its counsel Legal Counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such commentsCommission. The Investor shall use its reasonable best efforts to comment upon such prospectus within one (1) Business Day two Trading Days from the date the Investor receives the proposed final pre-filing version of such prospectus.

Appears in 10 contracts

Samples: Registration Rights Agreement (Highest Performances Holdings Inc.), Registration Rights Agreement (Jet Token Inc.), Registration Rights Agreement (CITIC Capital Acquisition Corp.)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time-to-time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with or submission to the SEC, and the Company shall give due consideration to all such commentscomments and/or reasonable recommendations. The Investor shall use its commercially reasonable best efforts to comment upon such prospectus within one (1) Business Day from the date the Investor receives the final pre-filing version of such prospectus.

Appears in 8 contracts

Samples: Registration Rights Agreement (Clean Vision Corp), Registration Rights Agreement (Growlife, Inc.), Registration Rights Agreement (Eco Innovation Group, Inc.)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales resales of the Registrable Securities by the Buyer under the Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor shall use its reasonable best efforts to comment upon provide any such prospectus comments within one (1) Business Day from the date the Investor receives the final pre-filing version of such prospectus.

Appears in 8 contracts

Samples: Registration Rights Agreement (Lithium Corp), Registration Rights Agreement (Costas Inc), Registration Rights Agreement (Aileron Therapeutics Inc)

Rule 424 Prospectus. The In addition to the Initial Registration Statement, the Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus such prospectuses and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the each Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prospectuses prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor shall use its reasonable best efforts to comment upon such any prospectus within one (1) two Business Day Days from the date the Investor receives the final pre-filing version of such prospectus.

Appears in 5 contracts

Samples: Securities Purchase Agreement (Integrated Media Technology LTD), Registration Rights Agreement (Digital Brands Group, Inc.), Registration Rights Agreement (FACT, Inc.)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor shall use its commercially reasonable best efforts to comment upon such prospectus within one (1) Business Day from the date the Investor receives the final pre-filing version of such prospectus.

Appears in 5 contracts

Samples: Registration Rights Agreement (Avinger Inc), Registration Rights Agreement (Amesite Inc.), Registration Rights Agreement (MetaStat, Inc.)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor shall use its commercially reasonable best efforts to comment upon such prospectus within one (1) Business Day from the date the Investor receives the final pre-filing version substantially complete draft of such prospectus.

Appears in 5 contracts

Samples: Registration Rights Agreement (CNS Pharmaceuticals, Inc.), Registration Rights Agreement (Brooklyn ImmunoTherapeutics, Inc.), Registration Rights Agreement (Moleculin Biotech, Inc.)

Rule 424 Prospectus. The In addition to the Initial Registration Statement, the Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus such prospectuses and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the each Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prospectuses prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor shall use its reasonable best efforts to comment upon such any prospectus within one two (12) Business Day business days from the date the Investor receives the final pre-filing version of such prospectus.

Appears in 5 contracts

Samples: Registration Rights Agreement (Jaguar Health, Inc.), Stock Plan Agreement (Jaguar Health, Inc.), Registration Rights Agreement (Riot Blockchain, Inc.)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time-to-time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor shall use its reasonable best efforts to comment upon such prospectus within one (1) Business Day from the date the Investor receives the final pre-filing version of such prospectus.

Appears in 4 contracts

Samples: Registration Rights Agreement (Cannabis Global, Inc.), Registration Rights Agreement (Propanc Biopharma, Inc.), Registration Rights Agreement (Propanc Biopharma, Inc.)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SECCommission, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the Registration Statement. The Investor Holders and its their counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SECCommission, and the Company shall give due consideration to all such comments. The Investor Each Holder shall use its reasonable best efforts to comment upon such prospectus within one (1) Business Trading Day from the date the Investor such Holder receives the final pre-filing version of such prospectus.

Appears in 4 contracts

Samples: Securities Purchase Agreement (ObsEva SA), Registration Rights Agreement (ObsEva SA), Registration Rights Agreement (ObsEva SA)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales resales of the Registrable Securities by the Buyer under the Registration StatementStatement during the Registration Period. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor shall use its commercially reasonable best efforts to comment upon provide any such prospectus comments within one (1) Business Day from the date the Investor receives the final pre-filing version of such prospectus.

Appears in 3 contracts

Samples: Registration Rights Agreement (Nutex Health, Inc.), Registration Rights Agreement (Heart Test Laboratories, Inc.), Registration Rights Agreement (HyreCar Inc.)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales resales of the Registrable Securities by the Buyer under the Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor shall use its commercially reasonable best efforts to comment upon provide any such prospectus comments within one (1) Business Day from the date the Investor receives the final pre-filing version of such prospectus.

Appears in 3 contracts

Samples: Registration Rights Agreement (Enochian Biosciences Inc), Registration Rights Agreement (Artelo Biosciences, Inc.), Registration Rights Agreement (eFFECTOR Therapeutics, Inc.)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor shall use its reasonable best efforts to comment upon such prospectus within one (1) Business Day from the date the Investor receives the proposed final pre-filing version of such prospectus.

Appears in 3 contracts

Samples: Registration Rights Agreement (Premier Exhibitions, Inc.), Registration Rights Agreement (Premier Exhibitions, Inc.), Registration Rights Agreement (Premier Exhibitions, Inc.)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor shall use its reasonable best efforts to comment upon such prospectus within one three (13) Business Day Days from the date the Investor receives the final pre-filing version of such prospectus.

Appears in 3 contracts

Samples: Registration Rights Agreement (AzurRx BioPharma, Inc.), Registration Rights Agreement, Registration Rights Agreement (AzurRx BioPharma, Inc.)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor shall use its commercially reasonable best efforts to comment upon such prospectus within one (1) Business Day from the date the Investor receives the final pre-filing version of such prospectus.

Appears in 3 contracts

Samples: Registration Rights Agreement (Regenerx Biopharmaceuticals Inc), Registration Rights Agreement (Lightwave Logic, Inc.), Registration Rights Agreement (Lightwave Logic, Inc.)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the Registration Statement. The Investor Investors and its their counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor Investors shall use its their reasonable best efforts to comment upon such prospectus within one (1) Business Trading Day from the date the Investor receives Investors receive the final pre-filing version of such prospectus.

Appears in 3 contracts

Samples: Registration Rights Agreement (Kma Global Solutions International Inc), Registration Rights Agreement (Kma Global Solutions International Inc), Registration Rights Agreement (Kma Global Solutions International Inc)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor shall use its reasonable best efforts to comment upon such prospectus comments received within one (1) Business Day from the date the Investor receives the final pre-filing version of such prospectus.

Appears in 2 contracts

Samples: Registration Rights Agreement (DPW Holdings, Inc.), Registration Rights Agreement (Digital Power Corp)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such reasonable comments. The Investor shall use its commercially reasonable best efforts to comment upon such prospectus within one (1) Business Day from the date the Investor receives the final pre-filing version of such prospectus.

Appears in 2 contracts

Samples: Registration Rights Agreement (Stealth BioTherapeutics Corp), Registration Rights Agreement (Invivo Therapeutics Holdings Corp.)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such reasonable comments. The Investor shall use its reasonable best efforts to comment upon such prospectus within one (1) Business Day from the date the Investor receives the final pre-filing version of such prospectus.

Appears in 2 contracts

Samples: Registration Rights Agreement (Plandai Biotechnology, Inc.), Registration Rights Agreement (Nuvilex, Inc.)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time-to-time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor shall use its reasonable best efforts to comment upon such prospectus within one (1) Business Day from the date the Investor receives the substantially final pre-filing version of such prospectus.

Appears in 2 contracts

Samples: Registration Rights Agreement (RemSleep Holdings Inc.), Registration Rights Agreement (RemSleep Holdings Inc.)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor shall use its commercially reasonable best efforts to comment upon such prospectus within one (1) Business Day from the date the Investor receives the final pre-filing version a substantially complete draft of such prospectus.

Appears in 2 contracts

Samples: Registration Rights Agreement (Zosano Pharma Corp), Registration Rights Agreement (Oncobiologics, Inc.)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the Registration Statement. The Investor Shareholders and its their counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor Shareholders shall use its their reasonable best efforts to comment upon such prospectus within one three (13) Business Day Days from the date the Investor Shareholders receives the final pre-filing version of such prospectus.

Appears in 2 contracts

Samples: Agreement and Plan of Merger (VistaGen Therapeutics, Inc.), Registration Rights Agreement (Super League Gaming, Inc.)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with re-sales of the Registrable Securities under the Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor shall use its reasonable best efforts to comment upon such prospectus within one (1) five Business Day Days from the date the Investor receives the proposed final pre-filing version of such prospectus.

Appears in 2 contracts

Samples: Registration Rights Agreement (Premier Exhibitions, Inc.), Registration Rights Agreement (Premier Exhibitions, Inc.)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor shall use its reasonable best efforts to comment upon such prospectus within one (1) Business Day from the date the Investor receives the final pre-filing version of such prospectus. Notwithstanding the foregoing, any prospectus supplement filed with the SEC solely to incorporate or include public information previously filed by the Company on Form 6-K may be filed without prior notice or review by Investor.

Appears in 2 contracts

Samples: Registration Rights Agreement (SMX (Security Matters) Public LTD Co), Registration Rights Agreement (SMX (Security Matters) Public LTD Co)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor shall use its commercially reasonable best efforts to comment upon such prospectus within one (1) Business Day from the date the Investor receives the substantially final pre-filing version of such prospectus.

Appears in 2 contracts

Samples: Registration Rights Agreement (Brookline Capital Acquisition Corp.), Registration Rights Agreement (Brookline Capital Acquisition Corp.)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SECCommission, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the Registration Statement. The Investor Sellers’ Representative and its his counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SECCommission, and the Company shall give due consideration to all such comments. The Investor Sellers’ Representative shall use its his reasonable best efforts to comment upon such prospectus within one (1) Business Trading Day from the date the Investor he receives the final pre-filing version of such prospectus.

Appears in 1 contract

Samples: Registration Rights Agreement (Cryptyde, Inc.)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities 1933 Act, the prospectus and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor shall use its reasonable best efforts to comment upon such prospectus within one (1) Business Day from the date the Investor receives the final pre-filing version of such prospectus. The Information provided by the investor for inclusion in the Registration Statement or and amendment or any includes prospectus shall be true and correct.

Appears in 1 contract

Samples: Registration Rights Agreement (Marani Brands, Inc.)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor shall use its reasonable best efforts to comment upon such prospectus within one (1) Business Day business day from the date the Investor receives the final pre-filing version of such prospectus.

Appears in 1 contract

Samples: Registration Rights Agreement (Generex Biotechnology Corp)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the Registration StatementStatement by the Company to the Investor. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus or prospectus supplement prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor shall use its reasonable best efforts to comment upon such prospectus or prospectus supplement within one (1) Business Day from the date the Investor receives the final pre-filing version of such prospectusprospectus or prospectus supplement, as the case may be.

Appears in 1 contract

Samples: Registration Rights Agreement (Provectus Pharmaceuticals Inc)

AutoNDA by SimpleDocs

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor shall use its reasonable best efforts to comment upon such prospectus within one (1) Business Day from the date the Investor receives the final pre-filing a substantially complete version of such prospectus.

Appears in 1 contract

Samples: Registration Rights Agreement (Leap Therapeutics, Inc.)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the S-1 Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor shall use its reasonable best efforts to comment upon such prospectus within one (1) Business Day from the date the Investor receives the final pre-filing version of such prospectus.

Appears in 1 contract

Samples: Registration Rights Agreement (Medizone International Inc)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the Registration Statement. The Investor Investors and its their counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor Investors shall use its their reasonable best efforts to comment upon such prospectus within one two (12) Business Day Days from the date the Investor Investors receives the final pre-filing version of such prospectus.

Appears in 1 contract

Samples: Registration Rights Agreement (Akers Biosciences, Inc.)

Rule 424 Prospectus. The In addition to the Initial Registration Statement, the Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus such prospectuses and prospectus supplements, if any, supplements to be used in connection with sales of the Registrable Securities under the each Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prospectuses prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor shall use its reasonable best efforts to comment upon such any prospectus within one two (12) Business Day business days from the date the Investor receives the final pre-filing version of such prospectus.

Appears in 1 contract

Samples: Registration Rights Agreement (Premier Biomedical Inc)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor shall use its reasonable best efforts to comment upon such prospectus within one (1) Business Day from the date the Investor receives the final pre-filing version of such prospectus.

Appears in 1 contract

Samples: Registration Rights Agreement (Advanced Cell Technology, Inc.)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the Registration Statement. The Investor Each Seller and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor Each Seller shall use its commercially reasonable best efforts to comment upon such prospectus within one (1) Business Day from the date the Investor Seller receives the final pre-filing version of such prospectus.

Appears in 1 contract

Samples: Registration Rights Agreement (Zevra Therapeutics, Inc.)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor shall use its reasonable commercial best efforts to comment upon such prospectus within one (1) Business Day from the date the Investor receives the final pre-filing version of such prospectus.

Appears in 1 contract

Samples: Registration Rights Agreement (IMAC Holdings, Inc.)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the each Registration StatementStatement (each a “Prospectus”). The Investor and its counsel shall have a reasonable opportunity to review and comment upon each such prospectus Prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such commentscomments of the Investor. The Investor shall use its reasonable best efforts to comment upon such prospectus within one (1) Business Day from the date the Investor receives the final pre-filing version of such prospectus.

Appears in 1 contract

Samples: Registration Rights Agreement (Brickell Biotech, Inc.)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus such prospectuses and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the each Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prospectuses prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor shall use its reasonable best efforts to comment upon such any prospectus within one two (12) Business Day Days from the date the Investor receives the final pre-filing version of such prospectus.

Appears in 1 contract

Samples: Registration Rights Agreement (Bigfoot Project Investments Inc)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor shall use its reasonable best efforts to comment upon such prospectus within one (1) Business Day from the date the Investor receives the final pre-filing version of such prospectus.

Appears in 1 contract

Samples: Registration Rights Agreement (Generex Biotechnology Corp)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SECCommission, pursuant to Rule 424 promulgated under the Securities Act, the prospectus prospectus, amendments and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such commentsCommission. The Investor shall use its reasonable best efforts to comment upon such prospectus within one two (12) Business Day Trading Days from the date the Investor receives the proposed final pre-filing version of such prospectus.

Appears in 1 contract

Samples: Registration Rights Agreement (Cyclone Power Technologies Inc)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales resales of the Registrable Securities under the Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor shall use its reasonable best efforts to comment upon such prospectus within one (1) Business Day from the date the Investor receives the final pre-filing version substantially complete draft of such prospectus.

Appears in 1 contract

Samples: Registration Rights Agreement (Helius Medical Technologies, Inc.)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 (or any successor rule) promulgated under the Securities ActAct (“Rule 424”), the prospectus and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor shall use its commercially reasonable best efforts to comment upon such prospectus within one (1) Business Day from the date the Investor receives the final pre-filing version of such prospectus.

Appears in 1 contract

Samples: Registration Rights Agreement (Clean Diesel Technologies Inc)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor shall use its reasonable best efforts to comment upon such prospectus within one (1) Business Day from the date the Investor receives the final pre-filing version a substantially complete draft of such prospectus.

Appears in 1 contract

Samples: Registration Rights Agreement (Aptevo Therapeutics Inc.)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the Registration StatementStatement during the Registration Period. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor shall use its reasonable best efforts to comment upon such prospectus within one (1) Business Day from the date the Investor receives the final pre-filing version of such prospectus.

Appears in 1 contract

Samples: Registration Rights Agreement (Humanigen, Inc)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the Registration Statement. The Investor Holders and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor Holders shall use its their commercially reasonable best efforts to comment upon such prospectus within one (1) Business Day from the date the Investor receives Holders receive the final pre-filing version of such prospectus.

Appears in 1 contract

Samples: Registration Rights Agreement (OWC Pharmaceutical Research Corp.)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give reasonable due consideration to all such reasonable comments. The Investor shall use its reasonable best efforts to comment upon such prospectus within one (1) Business Day business day from the date the Investor receives the final pre-filing version of such prospectus.

Appears in 1 contract

Samples: Registration Rights Agreement (VPR Brands, LP.)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor shall use its reasonable best efforts to comment upon such prospectus within one (1) Business Day from the date the Investor receives the final pre-filing version substantially complete draft of such prospectus.

Appears in 1 contract

Samples: Registration Rights Agreement (Inmune Bio, Inc.)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor shall use its reasonable best efforts to comment upon such prospectus within one (1) Business Day business day from the date the Investor receives the final pre-filing version of such prospectus.

Appears in 1 contract

Samples: Registration Rights Agreement (Trim Holding Group)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time time, file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under any Registration Statement during the Registration StatementPeriod. The Each Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor Investors shall use its reasonable best efforts to comment upon such prospectus within one two (12) Business Day business days from the date the Investor receives the final pre-filing version of such prospectus.

Appears in 1 contract

Samples: Registration Rights Agreement (Orbital Energy Group, Inc.)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor shall use its reasonable best efforts to comment upon such prospectus within one (1) Business Day from the date the Investor receives the final pre-filing version of such prospectus.

Appears in 1 contract

Samples: Registration Rights Agreement (Bruush Oral Care Inc.)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor shall use its reasonable best efforts to comment upon such prospectus within one (1I) Business Day from the date the Investor receives the final pre-filing version of such prospectus.

Appears in 1 contract

Samples: Registration Rights Agreement (Guided Therapeutics Inc)

Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales of the Registrable Securities under the Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due reasonable consideration to all such commentscomments the Company receives from the Investor or its counsel. The Investor shall use its reasonable best efforts to comment upon such prospectus within one (1) Business Day from the date the Investor receives the final pre-filing version of such prospectus.

Appears in 1 contract

Samples: Registration Rights Agreement (Dare Bioscience, Inc.)

Time is Money Join Law Insider Premium to draft better contracts faster.